Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hadar Kolb

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Scientific Reports|March 17, 2022
Differences in MS clinical and epidemiological characteristics between Ashkenazi and non-Ashkenazi Jewish patients in Israel: a retrospective single center studyArnon Karni, Gil Ben Noon, Tamara Shiner, et al.
Journal of Neurology|July 30, 2022
BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron wavesAlon Doron, Yoav Piura, Ifat Vigiser, et al.
Neuroimage. Clinical|September 28, 2022
From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesionsHadar Kolb, Omar Al-Louzi, Erin S Beck, et al.
International Journal of Molecular Sciences|March 6, 2021
Increased Expression of Ephrins on Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis Affects Oligodendrocyte DifferentiationMaya Golan, Avivit Krivitsky, Karin Mausner-Fainberg, et al.
CNS Drugs|November 13, 2019
Fingolimod Increases Brain-Derived Neurotrophic Factor Level Secretion from Circulating T Cells of Patients with Multiple SclerosisMaya Golan, Karin Mausner-Fainberg, Bassima Ibrahim, et al.
Journal of Neuroimmunology|March 6, 2016
Differential screening-selected gene aberrative in neuroblastoma (DAN) is increased in the CSF of patients with MS and may be induced by therapy with interferon-βKarin Mausner-Fainberg, Hadar Kolb, Moran Penn, et al.
Multiple Sclerosis and Related Disorders|December 23, 2023
Smartphone-based gait assessment for multiple sclerosisKeren Regev, Noa Eren, Ziv Yekutieli, et al.
Journal of Neurology|March 26, 2024
Real-World experience with efgartigimod in patients with myasthenia gravisLior Fuchs, Shahar Shelly, Ifat Vigiser, et al.
Journal of Neuroimmunology|June 22, 2024
Long-term cognitive outcomes in Susac syndrome: A case seriesYoav Piura, Noa Bregman, Gitit Kavé, et al.
Annals of Neurology|August 14, 2021
7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis LesionsHadar Kolb, Martina Absinta, Erin S Beck, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Scientific Reports|March 17, 2022
Differences in MS clinical and epidemiological characteristics between Ashkenazi and non-Ashkenazi Jewish patients in Israel: a retrospective single center studyArnon Karni, Gil Ben Noon, Tamara Shiner, et al.
Journal of Neurology|July 30, 2022
BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron wavesAlon Doron, Yoav Piura, Ifat Vigiser, et al.
Neuroimage. Clinical|September 28, 2022
From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesionsHadar Kolb, Omar Al-Louzi, Erin S Beck, et al.
International Journal of Molecular Sciences|March 6, 2021
Increased Expression of Ephrins on Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis Affects Oligodendrocyte DifferentiationMaya Golan, Avivit Krivitsky, Karin Mausner-Fainberg, et al.
CNS Drugs|November 13, 2019
Fingolimod Increases Brain-Derived Neurotrophic Factor Level Secretion from Circulating T Cells of Patients with Multiple SclerosisMaya Golan, Karin Mausner-Fainberg, Bassima Ibrahim, et al.
Journal of Neuroimmunology|March 6, 2016
Differential screening-selected gene aberrative in neuroblastoma (DAN) is increased in the CSF of patients with MS and may be induced by therapy with interferon-βKarin Mausner-Fainberg, Hadar Kolb, Moran Penn, et al.
Multiple Sclerosis and Related Disorders|December 23, 2023
Smartphone-based gait assessment for multiple sclerosisKeren Regev, Noa Eren, Ziv Yekutieli, et al.
Journal of Neurology|March 26, 2024
Real-World experience with efgartigimod in patients with myasthenia gravisLior Fuchs, Shahar Shelly, Ifat Vigiser, et al.
Journal of Neuroimmunology|June 22, 2024
Long-term cognitive outcomes in Susac syndrome: A case seriesYoav Piura, Noa Bregman, Gitit Kavé, et al.
Annals of Neurology|August 14, 2021
7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis LesionsHadar Kolb, Martina Absinta, Erin S Beck, et al.
Pageof 3